NASDAQ: PTGX · Biotechnology
Over the past week, Protagonist Therapeutics (PTGX) saw 14 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 50% bullish across the tracked sources. Wall Street is more constructive, with 13 of 13 analysts rating PTGX a buy.
There is little buzz around PTGX this week and broad agreement on direction, which is why it reads as a Hold.
Wall Street’s 100% buy share sits next to a crowd that ranges from News at 50% to X at 50%. No other tracker puts the two side by side.
13 analysts have weighed in: a Strong Buy consensus: 13 buy calls against 0 sell, with an average 12-month price target of $174.69.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits right on the neutral line, momentum is improving and the 2 sources broadly agree, so the read is Hold rather than a clear buy or sell.
Analysts sit 50 points above the crowd average of 50%, the professionals are more constructive than retail. The split is inside the crowd: X reads 50% bullish while News sits at 50%, a 0-point spread that single-source trackers miss.
Over the 30-day window, Protagonist Therapeutics (PTGX) buzz held moderate around 40.4 while the price drifted down 3.9% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 735K shares. Updated Oct 03, 2026. Over the last 7 trading days, PTGX gained 2.0%. Buzz activity in the recent week averaged 38.5 and was relatively stable, swinging between 32.2 and 50.8. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 12 of the 15 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Reddit data for this stock this week.
No Polymarket data for this stock this week.
Query sentiment for PTGX and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live PTGX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 03, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (13 / 0 / 0) |
| Crowd bullish (7d) | 50% |
| Avg price target | $174.69 |
| Most bullish source | X, 50% |
| Most bearish source | News, 50% |
| Sentiment spread | 0 pts |
| Mentions (7d) | 14 |
| Market cap | $9.01B |
| P/E · Forward P/E | 135.1 · 36.9 |
| EPS · Beta | $1.03 · 1.8 |
| Revenue (TTM) | $282M · 29% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from X and News sources, Protagonist Therapeutics (PTGX) currently carries an Adanos hold signal with 63/100 conviction. The current cross-source average reads 50% bullish across 2 active sources. Those sources contribute 14 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
The crowd reads split on Protagonist Therapeutics (PTGX), averaging 50% bullish across 2 tracked sources over the last 7 days. The two ends of the range are X at 50% bullish and News at 50%, a 0-point spread. On the professional side, 13 of 13 analysts rate PTGX a buy.
Of the 13 analysts covering Protagonist Therapeutics (PTGX), 13 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $174.69. That puts the street ahead of the crowd, which averages 50% bullish.
Protagonist Therapeutics (PTGX)'s cross-source average is mixed at 50% bullish. All 2 tracked sources sit at 50% bullish. News reads 50% bullish and x coverage is the most negative at 50% bullish. The combined signal points to broad mixed pressure with 63/100 conviction.
The cross-source average is mixed for Protagonist Therapeutics (PTGX) at 50% bullish. All 2 tracked sources sit at 50% bullish. The most bearish reading is x at 50% bullish. 3-day activity momentum is rising across X. The hold signal carries 63/100 conviction.
X is the dominant discussion channel with 10 mentions (71% of total volume). News contributes 4 mentions. The cross-source average is mixed at 50% bullish, while x is the only source with rising 3-day activity. All 2 tracked sources sit at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. PTGX's hold signal at 63/100 conviction reflects a mixed cross-source average at 50% bullish. All 2 tracked sources sit at 50% bullish. It is a research shortcut, not financial advice.
The PTGX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key